130 related articles for article (PubMed ID: 1618230)
21. Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.
Apostolopoulos DJ; Papandrianos NI; Symeonidis A; Spyridonidis T; Alexiou S; Zampakis P; Savvopoulos C; Vassilakos PJ; Matsouka P
Ann Nucl Med; 2010 Nov; 24(9):639-47. PubMed ID: 20799079
[TBL] [Abstract][Full Text] [Related]
22. 99mTc-labelled rituximab, a new non-Hodgkin's lymphoma imaging agent: first clinical experience.
Gmeiner Stopar T; Fettich J; Zver S; Mlinaric-Rascan I; Hojker S; Socan A; Peitl PK; Mather S
Nucl Med Commun; 2008 Dec; 29(12):1059-65. PubMed ID: 18987526
[TBL] [Abstract][Full Text] [Related]
23. Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.
Stalteri MA; Mather SJ
Eur J Nucl Med; 1996 Feb; 23(2):178-87. PubMed ID: 8925853
[TBL] [Abstract][Full Text] [Related]
24. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA
Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020
[TBL] [Abstract][Full Text] [Related]
25. 99mTc-depreotide tumour uptake in patients with non-Hodgkin's lymphoma.
Bushnell DL; Menda Y; Madsen MT; Link BK; Kahn D; Truhlar SM; Juweid M; Shannon M; Murguia JS
Nucl Med Commun; 2004 Aug; 25(8):839-43. PubMed ID: 15266180
[TBL] [Abstract][Full Text] [Related]
26. Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?
Sharkey RM; Brenner A; Burton J; Hajjar G; Toder SP; Alavi A; Matthies A; Tsai DE; Schuster SJ; Stadtmauer EA; Czuczman MS; Lamonica D; Kraeber-Bodere F; Mahe B; Chatal JF; Rogatko A; Mardirrosian G; Goldenberg DM
J Nucl Med; 2003 Dec; 44(12):2000-18. PubMed ID: 14660727
[TBL] [Abstract][Full Text] [Related]
27. Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancer.
Tibben JG; Massuger LF; Claessens RA; Schijf CP; Pak KY; Strijk SP; Kenemans P; Corstens FH
Nucl Med Commun; 1992 Dec; 13(12):885-93. PubMed ID: 1465272
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and staging of children's lymphoma using the technetium-labelled somatostatin analogue, 99mTc-depreotide.
Cholewinski W; Kowalczyk JR; Stefaniak B; Stefaniak J; Poniatowicz-Frasunek E; Tarkowska A
Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):820-4. PubMed ID: 14762697
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of thrombus detection in a rabbit model using a technetium-99m-labelled anti-fibrin monoclonal antibody.
Lee FT; Milner LJ; Boniface GR; Bautovich GJ; Weedon AR; Bundesen PG; Rylatt DB; Walker KZ
Immunol Cell Biol; 1992 Jun; 70 ( Pt 3)():173-9. PubMed ID: 1452220
[TBL] [Abstract][Full Text] [Related]
30. Clinical experience with Tc-99m labeled (N2S2) anti-melanoma antibody fragments and single photon emission computed tomography.
Wahl RL; Swanson NA; Johnson JW; Natale R; Petry NA; Mallette S; Kasina S; Reno J; Sullivan K; Abrams P
Am J Physiol Imaging; 1992; 7(2):48-58. PubMed ID: 1419120
[TBL] [Abstract][Full Text] [Related]
31. Radioimmunoscintigraphy (RIS) with bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL).
Lamonica D; Czuczman M; Nabi H; Klippenstein D; Grossman Z
Cancer Biother Radiopharm; 2002 Dec; 17(6):689-97. PubMed ID: 12537673
[TBL] [Abstract][Full Text] [Related]
32. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.
Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C
J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546
[TBL] [Abstract][Full Text] [Related]
33. Detection of hepatocellular carcinoma with a new alpha-fetoprotein antibody imaging kit.
Dresel S; Kirsch CM; Tatsch K; Zachoval R; Hahn K; Goldenberg DM
J Clin Oncol; 1997 Jul; 15(7):2683-90. PubMed ID: 9215841
[TBL] [Abstract][Full Text] [Related]
34. Visualization of non-Hodgkin's lymphoma by high dosed somatostatin receptor specific scintigraphy and extended single photon emission tomography.
Lipp RW; Schnedl WJ; Aglas F; Ranner G; Beham-Schmid C; Leb G; Sill H
Acta Med Austriaca; 1999; 26(3):105-8. PubMed ID: 10520379
[TBL] [Abstract][Full Text] [Related]
35. Prostatic radioimmunoscintigraphy: preliminary results using technetium-labelled monoclonal antibody, CYT-351.
Feneley MR; Chengazi VU; Kirby RS; Nimmon CC; Granowska M; Mather SJ; Ellison D; Granowski AR; Britton KE
Br J Urol; 1996 Mar; 77(3):373-81. PubMed ID: 8814841
[TBL] [Abstract][Full Text] [Related]
36. Estimates of red marrow dose by sacral scintigraphy in radioimmunotherapy patients having non-Hodgkin's lymphoma and diffuse bone marrow uptake.
Juweid M; Sharkey RM; Siegel JA; Behr T; Goldenberg DM
Cancer Res; 1995 Dec; 55(23 Suppl):5827s-5831s. PubMed ID: 7493354
[TBL] [Abstract][Full Text] [Related]
37. Imaging of low-grade bone infection with a technetium-99m labelled monoclonal anti-NCA-90 Fab' fragment in patients with previous joint surgery.
Ivanćević V; Perka C; Hasart O; Sandrock D; Munz DL
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):547-51. PubMed ID: 11914895
[TBL] [Abstract][Full Text] [Related]
38. Targeting of liver metastases of colorectal cancer with IgG, F(ab')2, and Fab' anti-carcinoembryonic antigen antibodies labeled with 99mTc: the role of metabolism and kinetics.
Behr T; Becker W; Hannappel E; Goldenberg DM; Wolf F
Cancer Res; 1995 Dec; 55(23 Suppl):5777s-5785s. PubMed ID: 7493346
[TBL] [Abstract][Full Text] [Related]
39. 99mTC-labelled antigranulocyte monoclonal antibody FAB' fragments versus echocardiography in the diagnosis of subacute infective endocarditis.
Gratz S; Raddatz D; Hagenah G; Behr T; Béhé M; Becker W
Int J Cardiol; 2000 Aug; 75(1):75-84. PubMed ID: 11054510
[TBL] [Abstract][Full Text] [Related]
40. Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma.
Camacho X; Machado CL; García MF; Gambini JP; Banchero A; Fernández M; Oddone N; Bertolini Zanatta D; Rosal C; Buchpiguel CA; Chammas R; Riva E; Cabral P
Oncology; 2017; 92(4):229-242. PubMed ID: 28196364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
